AN2 THERAPEUTICS INC's ticker is and the CUSIP is 037326105. A total of 39 filers reported holding AN2 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 233,330 | $4,055,000 | 1.50% |
| RA Capital Management | 3,773,517 | $65,584,000 | 1.40% |
| BVF INC/IL | 1,616,665 | $28,098,000 | 1.16% |
| Avidity Partners Management LP | 742,630 | $12,907,000 | 0.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 716,538 | $12,453,000 | 0.25% |
| Alyeska Investment Group, L.P. | 105,718 | $1,837,000 | 0.02% |
| Woodline Partners LP | 76,145 | $1,323,000 | 0.02% |
| Citadel Advisors | 1,336,983 | $23,237,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 5,726 | $100,000 | 0.00% |
| CITIGROUP INC | 134,545 | $2,338,000 | 0.00% |